Orgenesis Inc. Common Stock
ORGS
ORGS was delisted on the 18th of October, 2024.
16 hedge funds and large institutions have $11.6M invested in Orgenesis Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 0 closing their positions.
213% more capital invested
Capital invested by funds: $3.7M → $11.6M (+$7.87M)
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
14% more funds holding
Funds holding: 14 → 16 (+2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PF
Phoenix Financial
Givatayim,
Israel
|
+$4.92M |
| 2 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$4.85M |
| 3 |
Renaissance Technologies
New York
|
+$101K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$54.8K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$31.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$17.1K |
| 2 |
BlackRock
New York
|
-$8.26K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$1.27K |
ORGS Hedge Fund Activity: Q1 2020 in Review
16 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Orgenesis Inc. Common Stock (ORGS) for Q1 2020, worth a combined $11.6M — up 213% from $3.7M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new ORGS positions and 0 closed out — a net gain of 2 holders — while 4 added to existing stakes and 3 trimmed.
The largest buyer was Phoenix Financial, adding an estimated $4.92M. The largest seller was Wells Fargo, cutting an estimated $17.1K.
- 16 institutional investors held Orgenesis Inc. Common Stock (ORGS) as of Q1 2020, up from 14 in Q4 2019.
- Funds reported $11.6M of Orgenesis Inc. Common Stock stock for Q1 2020, up 213% quarter-over-quarter.
- 2 funds opened new Orgenesis Inc. Common Stock positions in Q1 2020 and 0 closed out, a net change of +2 holders.
- The largest Orgenesis Inc. Common Stock buyer in Q1 2020 was Phoenix Financial, an estimated $4.92M added.
- The largest Orgenesis Inc. Common Stock seller in Q1 2020 was Wells Fargo, an estimated $17.1K sold.
Based on aggregated 13F filings for Q1 2020.